Related Experiment Video

Updated: Jun 5, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme

Kristine K Macartney1, Mamta Porwal, Dianne Dalton

  • 1National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. kristinm@chw.edu.au

Journal of Paediatrics and Child Health
|January 20, 2011
PubMed

Insights

Rotavirus immunisation significantly reduced hospitalisations by 75% in young children. The vaccine also decreased hospital-acquired rotavirus infections, demonstrating broad public health benefits.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health Surveillance

Background:

  • Rotavirus gastroenteritis is a leading cause of severe diarrheal disease in infants and young children globally.
  • The introduction of rotavirus vaccines into national immunization programs aims to reduce the burden of rotavirus-associated hospitalizations.
  • Understanding the real-world impact of rotavirus vaccination is crucial for public health policy and disease prevention strategies.

Purpose of the Study:

  • To evaluate the effectiveness of rotavirus immunisation on hospitalisation rates for rotavirus gastroenteritis in young children.
  • To assess the impact of the vaccine program on hospital-acquired (nosocomial) rotavirus infections.
  • To determine the influence of rotavirus vaccination on herd immunity within a pediatric population.

Main Methods:

  • Retrospective analysis of annual hospitalisations for rotavirus gastroenteritis at a tertiary pediatric hospital from 2001 to 2009.
  • Data collection included 6 years pre-vaccine introduction and 2.5 years post-vaccine introduction to the National Immunisation Program.
  • Prospective data collection for hospital-acquired rotavirus gastroenteritis from 2007 to 2009.

Main Results:

  • A 75% decline in rotavirus gastroenteritis hospitalisations was observed in the two full seasons following vaccine introduction (2008-2009) compared to the pre-vaccine period (2001-2006).
  • The most significant reduction was in infants under 12 months (93%), but substantial decreases were noted across all age groups, including unvaccinated children, suggesting herd immunity.
  • A notable reduction in nosocomial rotavirus gastroenteritis occurred between 2007 and 2009, indicating decreased virus transmission within the hospital setting.

Conclusions:

  • The implementation of a nationally funded rotavirus immunisation program in Australia led to a significant decrease in pediatric hospitalisations for rotavirus gastroenteritis.
  • The study provides evidence of reduced nosocomial infections, highlighting the vaccine's role in controlling virus spread within healthcare facilities.
  • Rotavirus vaccination demonstrates substantial public health benefits, impacting both community and hospital settings, and protecting children of all ages through direct and indirect effects.
Abstract

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...